Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Sida 1 från 16 resultat
Method for treating insult to neurons prone to Parkinson's degeneration employing an ATP-sensitive potassium channel blocker
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a method for treating neuronal insult, such as caused by lack of oxygen, in neurons prone to Parkinsonian degeneration, by administering to a patient an ATP-sensitive potassium channel blocker.
BACKGROUND OF THE INVENTION
A species of potassium
Food products having increased potassium content and use thereof in enhancing gastric acid response
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention relates to coffee products having an increased content of potassium and to the use of foods and beverages having an increased potassium content to enhance the gastric acid response in persons with low gastric acid secretion, especially individuals having
Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention belongs to the field of pharmacy. In particular, the present invention relates to a class of novel compounds agonist which can be used as potassium ion channels agonist, the preparation method thereof, and the use of the compounds agonist or the pharmaceutically
Method for the treatment of nervous system degeneration
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
This invention relates to the treatment of degenerative diseases of the central nervous system, such as those associated with aging and senile dementia of the Alzheimer's type (hereinafter referred to by the abbreviation SDAT). In particular, this invention also relates
Heterocycles as potassium channel modulators
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
Heterocycles as potassium channel modulators
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
Heterocycles as potassium channel modulators
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
Ion channels are cellular proteins that regulate the flow of ions, including calcium, potassium, sodium and chloride, into and out of cells. These channels are present in all human cells and affect such processes as nerve transmission, muscle contraction and cellular
Methods of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to novel methods for the treatment or prevention of glaucoma, ocular hypertension, and other ophthalmic disorders exhibiting elevated intraocular pressure, as well as ocular disorders characterized by retinal neurodegeneration or edema including
Composition of orally administered nutritional supplements to repair articular cartilage
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF INVENTION
The present invention is directed to compositions of nutritional supplements. Specifically, the invention relates to a unique compound that, when ingested by mammals, is capable of repairing and regenerating articular cartilage, resulting in relief from associated symptoms of
Polychloroprene latex, rubber composition and dip-molded article
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national stage application of PCT Application No. PCT/JP2012/058391, filed Mar. 29, 2012, which claims the benefit of Japanese Application No. JP 2011-084819, filed Apr. 6, 2011, in the Japanese Patent Office. All disclosures of the
Water-soluble aspirin composition
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates in general to aspirin compositions, and in particular to a new and useful water-soluble aspirin composition and the method of making the same.
Aspirin is the most widely used drug in the world. It has a number of important uses in
Material for non-aqueous electrolyte secondary battery negative electrode
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to an electrode for a non-aqueous electrolyte secondary battery negative electrode containing a carbonaceous material and graphite.
BACKGROUND ART
In recent years, the notion of mounting large lithium-ion secondary batteries, having high energy density
PH adjustors and drinks using the same
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The invention relates to pH adjustors for drinks comprising a potassium salt as an active ingredient and to drinks using the pH adjustors.
BACKGROUND OF THE INVENTION
There are many species of coffees having different aromas and tastes (e.g., sweetness, mellowness, bitterness,
Composition usable in the treatment of cancer
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase patent application of International Application Ser. No. PCT/IB2011/002984, filed on Dec. 9, 2011, and which claims the benefits of European Patent Application No. 10015591.0, and of Italian Patent Application No.
Method for treating ischemic oranoxic insult to neurons employing quinine
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to a method for treating neuronal insult, such as caused by lack of oxygen, in neurons prone to Parkinsonian degeneration, by administering to a patient an ATP-sensitive potassium channel blocker.
BACKGROUND OF THE INVENTION
A species of potassium
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
